Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
OMCL Transcript
Omnicell, Inc. (OMCL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral6-9
Omnicell, Inc. (OMCL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-12
Omnicell, Inc. (OMCL) Q1 2026 Earnings Call Transcript
Unknown4-28
The earnings call summary reveals a decline in key financial metrics: revenue decreased by 5%, gross margin declined by 2 percentage points, operating expenses increased by 10%, and net income decreased by 15%. These factors are compounded by a 20% decline in cash flow from operations. The lack of strategic initiatives or positive operational updates further supports a negative sentiment. Given the company's market cap, the stock price is likely to react negatively, falling within the -2% to -8% range over the next two weeks.
Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript
Positive2-5
The earnings call reveals a positive outlook with increased revenue and EPS guidance, improved margins, and strategic investments in product development and market expansion. The Q&A section highlights strong competitive positioning and confidence in new product launches. Although there are some uncertainties, such as the impact of tariff costs and the timeline for new product adoption, the company's proactive strategies and optimistic guidance suggest a positive sentiment. Given the market cap of approximately $1.2 billion, the stock is likely to see a positive reaction, between 2% and 8%, over the next two weeks.
OMCL Slides
Omnicell Q4 2025 slides: EPS miss drives 15% stock drop despite revenue growth2026-02-05
Omnicell Q3 2025 slides: Medication management leader beats estimates, accelerates SaaS growth2025-10-30
Omnicell Q2 2025 slides: Revenue up 5%, shares jump on recurring revenue growth2025-07-31
Omnicell Q1 2025 slides: revenue up 10%, recurring revenue reaches 56% of total2025-05-06
OMCL Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
